Gene Expression Data Analysis in nSolver: Application of the QC Metrics to Refine a Data Set
Let's get deeper into your analysis of NanoString nCounter gene expression data in this webinar to walk through application of the Quality Control metrics in order to refine a data set. Field Applications Scientist Lori Mull, PhD, will do a live demonstration in nSolver data analysis software, covering this topic. As always, questions and interaction are encouraged.
A Walkthrough of the New Whole Transcriptome Atlas Spatial Profiling Application with NGS Readout
As seen in Nature Methods, January 2021: Method of the Year 2020- spatially resolved transcriptomics. The GeoMx® Whole Transcriptome Atlas (WTA) is designed for comprehensive profiling of spatial biology. Profile the RNA expression over 18,000 genes in human and over 21,000 genes in mouse with spatial resolution in any region of interest from a single tissue section using GeoMx Digital Spatial Profiling.
Resolving Tumor Microenvironment Challenges through GeoMx Digital Spatial Profiling
NanoString’s GeoMx Digital Spatial Profiler ignited the spatial biology evolution and is the leading digital technology offering multiplexed measurement of protein and nucleic acids with an unparalleled level of precision. Quantify 10’s 10,000’s targets (RNA or protein) on a fresh frozen or formalin-fixed, paraffin-embedded (FFPE) tissue section in a completely non destructive manner.
• Discover novel protein and RNA biomarkers through spatial enrichment
• Interrogate regions of interest and segment compartments across your sample
• Access fresh, frozen and archived FFPE to fully profile critical spatial biology
• Validated protein panels offer quantifiable insight for Neurobiology and Immune Oncology
• Cancer Transcriptome Atlas targets 1833 genes of critical significance.
• Whole Transcriptome Atlas for Mouse or Human allows unbiased analysis of tissue.
NanoString Basics: A Journey from nCounter Expression Profiling through GeoMx Digital Spatial Technology
How familiar are you with the capabilities of NanoString Technology? Join us for this webinar to cover the basis of NanoString's barcode technology spanning from expression analysis of DNA, RNA, miRNA, and/or Protein to digital spatial expression profiling of RNA and Protein.
Rapid and Easy Generation of Gene Expression Data from Preclinical through Clinical Drug Development
Gene expression studies are an integral part of the drug development process, from discovery and biomarker development, through to clinical trials. Each stage of development presents its own challenges. Nanostring’s curated gene-expression panels provide next-day data, with each panel covering an area of interest with topics varying from Immune Exhaustion to Tumor Signaling, or Fibrosis. Significant panel content is available in the areas of immuno-oncology, autoimmunity, and neurodegeneration, as well as a selection of clinically validated assays. We will cover some examples of preclinical and clinical-stage studies that used Nanostring for gene expression profiling as well as general recommendations for running a study with a Nanostring panel.
Advancements in Infectious Disease Research, featuring Special Guest Jonathan Guito, PhD, of the CDC
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. Join us for an overview of NanoString capabilities in infectious disease research including COVID-19 and Host Response research tools with Field Applications Scientist Jerid Robinson, PhD, followed by a special presentation by Jonathan Guito, PhD, of the Viral Special Pathogens Branch, NCEZID, Centers for Disease Control and Prevention. Dr. Guito will detail his work entitled "Understanding how Marburg virus-infected natural host bats are immunoprotected from severe clinical disease".